Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System

NCT02663323 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System

Sponsor

Meril Life Sciences Pvt. Ltd.